RemeGen Co., Ltd. (HKG:9995)
Hong Kong · Delayed Price · Currency is HKD 82.05
+0.15 (0.18%)
At close: Feb 23, 2026
RemeGen Employees
RemeGen had 3,070 employees as of June 30, 2025.
Employees
3,070
Change
n/a
Growth
n/a
Revenue / Employee
811.87K HKD
Profits / Employee
-345.34K HKD
Market Cap
57.17B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 3,070 | - | - |
| Dec 31, 2024 | 2,999 | -616 | -17.04% |
| Dec 31, 2023 | 3,615 | 283 | 8.49% |
| Dec 31, 2022 | 3,332 | 1,211 | 57.10% |
| Dec 31, 2021 | 2,121 | 755 | 55.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sino Biopharmaceutical | 23,056 |
| 3SBio | 6,268 |
| Genscript Biotech | 5,769 |
| Shanghai Henlius Biotech | 3,537 |
| Akeso | 3,529 |
| Shanghai Junshi Biosciences | 2,670 |
| Sichuan Kelun-Biotech Biopharmaceutical | 1,870 |
| Biocytogen Pharmaceuticals (Beijing) | 1,306 |